CSF from six patients (three PD, and three controls) were mixed, respectively, with a pre-filtered α-synuclein monomer solution in 50 mM Tris-HCl and 150 mM NaCl at a v/v ratio of 1:9. Final concentration of α-synuclein was 500 µg/mL. The samples were incubated with continuous shaking (600 rpm) at 37 °C , and collected at days 0, 2, and 4. The collected samples were centrifuged immediately at 13,500 rpm at 4 °C for 30 min, and the supernatants were used for the detection of oligomers by western blot analysis. The primary antibody used for western blot was a mouse anti-human α-synuclein oligomer-specific antibody (ASyO5; AS13 2718, Agrisera, Vännäs, Sweden) and the secondary antibody was a sheep anti-mouse peroxidase-linked antibody (NA931; GE Healthcare, Little Chalfont, UK). Oligomerization activity was calculated by the day 4/day 0 ratio of the total intensity of the bands at 33 and 55 kDa. 
